Health · Published November 9, 2026 at 3:40 PM CST · Updated November 12, 2026 at 1:10 PM CST

FDA Orders New Eye Risk Warning for GLP-1 Drugs

Left 13Center 7Right 4

What everyone agrees on

The FDA ordered drugmakers to add a new warning to GLP-1 medications.
The warning covers a rare eye condition linked to a potential increased risk of vision loss.
The warning applies to drugs such as Ozempic, Wegovy and Zepbound, used for weight loss and diabetes.

Each fact above was reported by outlets on the left, center and right.

Left-leaning outlets · 13

Left-leaning outlets focused on the FDA's announcement and listed the specific drug brands affected by the new warning.

Center-leaning outlets · 7

Center-leaning outlets focused on the FDA's safety labeling announcement and the regulatory process behind it.

Right-leaning outlets · 4

No coverage from the right-leaning outlets we read.

A simple way to report a wrong or missing fact, with no sign-up, is coming soon. Every correction will be listed publicly.

This page was written by AI from each outlet's headline and short description, following our published rules. Always check the original reporting.